Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

Prospects and challenges of a new live tuberculosis vaccine.

Achkar JM.

Lancet Respir Med. 2019 Sep;7(9):723-725. doi: 10.1016/S2213-2600(19)30277-2. Epub 2019 Aug 12. No abstract available.

PMID:
31416770
2.

Underutilization of Combination Anti-TNF Therapy in Population-based Study.

Kurowski JA, Achkar JP.

Inflamm Bowel Dis. 2019 Jul 24. pii: izz150. doi: 10.1093/ibd/izz150. [Epub ahead of print] No abstract available.

PMID:
31340027
3.

Tailored Medical Management of the Complex Postoperative Crohn's Disease Patient.

Achkar JP.

Clin Colon Rectal Surg. 2019 Jul;32(4):225-230. doi: 10.1055/s-0039-1683853. Epub 2019 Jul 2. Review.

PMID:
31275068
4.

Combining urine lipoarabinomannan with antibody detection as a simple non-sputum-based screening method for HIV-associated tuberculosis.

Younis H, Kerschbaumer I, Moon JY, Kim RS, Blanc CJ, Chen T, Wood R, Lawn S, Achkar JM.

PLoS One. 2019 Jun 25;14(6):e0218606. doi: 10.1371/journal.pone.0218606. eCollection 2019.

5.

Jejunal necrosis after internal herniation of Roux limb through Petersen defect.

Bhagya Rao B, Garber A, Achkar JP.

Gastrointest Endosc. 2019 Aug;90(2):317-318. doi: 10.1016/j.gie.2019.04.198. Epub 2019 Apr 5. No abstract available.

PMID:
30959028
6.

Factors Associated With Sputum Culture-Negative vs Culture-Positive Diagnosis of Pulmonary Tuberculosis.

Nguyen MH, Levy NS, Ahuja SD, Trieu L, Proops DC, Achkar JM.

JAMA Netw Open. 2019 Feb 1;2(2):e187617. doi: 10.1001/jamanetworkopen.2018.7617.

7.

Acupuncture in Inflammatory Bowel Disease.

Song G, Fiocchi C, Achkar JP.

Inflamm Bowel Dis. 2019 Jun 18;25(7):1129-1139. doi: 10.1093/ibd/izy371.

PMID:
30535303
8.

Influence of pretreatment conditions on lignocellulosic fractions and methane production from grape pomace.

El Achkar JH, Lendormi T, Salameh D, Louka N, Maroun RG, Lanoisellé JL, Hobaika Z.

Bioresour Technol. 2018 Jan;247:881-889. doi: 10.1016/j.biortech.2017.09.182. Epub 2017 Sep 28.

PMID:
30060426
9.

Serum-Mediated Cleavage of Bacillus anthracis Protective Antigen Is a Two-Step Process That Involves a Serum Carboxypeptidase.

Goldman DL, Nieves E, Nakouzi A, Rivera J, Phyu EE, Win TH, Achkar JM, Casadevall A.

mSphere. 2018 Jun 27;3(3). pii: e00091-18. doi: 10.1128/mSphere.00091-18. Print 2018 Jun 27.

10.

Utilization and Clinical Value of Diagnostic Modalities for Tuberculosis in a High HIV Prevalence Setting.

Gati S, Chetty R, Wilson D, Achkar JM.

Am J Trop Med Hyg. 2018 Aug;99(2):317-322. doi: 10.4269/ajtmh.17-0965. Epub 2018 Jun 7.

11.

Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis.

Achkar JM, Prados-Rosales R.

Curr Opin Immunol. 2018 Aug;53:30-37. doi: 10.1016/j.coi.2018.04.004. Epub 2018 Apr 12. Review.

12.

Soluble CD14 as a Diagnostic Biomarker for Smear-Negative HIV-Associated Tuberculosis.

Liu Y, Ndumnego OC, Chen T, Kim RS, Jenny-Avital ER, Ndung'u T, Wilson D, Achkar JM.

Pathogens. 2018 Feb 27;7(1). pii: E26. doi: 10.3390/pathogens7010026.

13.

Anaerobic digestion of grape pomace: Effect of the hydraulic retention time on process performance and fibers degradability.

El Achkar JH, Lendormi T, Salameh D, Louka N, Maroun RG, Lanoisellé JL, Hobaika Z.

Waste Manag. 2018 Jan;71:137-146. doi: 10.1016/j.wasman.2017.11.005. Epub 2017 Nov 6.

PMID:
29122460
14.

Multiplexed Nucleic Acid Programmable Protein Arrays.

Yu X, Song L, Petritis B, Bian X, Wang H, Viloria J, Park J, Bui H, Li H, Wang J, Liu L, Yang L, Duan H, McMurray DN, Achkar JM, Magee M, Qiu J, LaBaer J.

Theranostics. 2017 Sep 20;7(16):4057-4070. doi: 10.7150/thno.20151. eCollection 2017.

15.

The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010-2014.

Brennan MJ, Tanner R, Morris S, Scriba TJ, Achkar JM, Zelmer A, Hokey DA, Izzo A, Sharpe S, Williams A, Penn-Nicholson A, Erasmus M, Stylianou E, Hoft DF, McShane H, Fletcher HA.

Clin Vaccine Immunol. 2017 Sep 5;24(9). pii: e00142-17. doi: 10.1128/CVI.00142-17. Print 2017 Sep. Review.

16.

Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine.

Prados-Rosales R, Carreño L, Cheng T, Blanc C, Weinrick B, Malek A, Lowary TL, Baena A, Joe M, Bai Y, Kalscheuer R, Batista-Gonzalez A, Saavedra NA, Sampedro L, Tomás J, Anguita J, Hung SC, Tripathi A, Xu J, Glatman-Freedman A, Jacobs WR Jr, Chan J, Porcelli SA, Achkar JM, Casadevall A.

PLoS Pathog. 2017 Mar 9;13(3):e1006250. doi: 10.1371/journal.ppat.1006250. eCollection 2017 Mar.

17.

Identification of Antibody Targets for Tuberculosis Serology using High-Density Nucleic Acid Programmable Protein Arrays.

Song L, Wallstrom G, Yu X, Hopper M, Van Duine J, Steel J, Park J, Wiktor P, Kahn P, Brunner A, Wilson D, Jenny-Avital ER, Qiu J, Labaer J, Magee DM, Achkar JM.

Mol Cell Proteomics. 2017 Apr;16(4 suppl 1):S277-S289. doi: 10.1074/mcp.M116.065953. Epub 2017 Feb 21.

18.

Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications.

Ombrello MJ, Arthur VL, Remmers EF, Hinks A, Tachmazidou I, Grom AA, Foell D, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Ilowite NT, Mellins ED, Russo R, Len C, Hilario MO, Oliveira S, Yeung RS, Rosenberg AM, Wedderburn LR, Anton J, Haas JP, Rosen-Wolff A, Minden K, Tenbrock K, Demirkaya E, Cobb J, Baskin E, Signa S, Shuldiner E, Duerr RH, Achkar JP, Kamboh MI, Kaufman KM, Kottyan LC, Pinto D, Scherer SW, Alarcón-Riquelme ME, Docampo E, Estivill X, Gül A; British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group, Inception Cohort of Newly Diagnosed Patients with Juvenile Idiopathic Arthritis (ICON-JIA) Study Group, Childhood Arthritis Prospective Study (CAPS) Group, Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators, Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group, Biologically Based Outcome Predictors in JIA (BBOP) Group, Langefeld CD, Thompson S, Zeggini E, Kastner DL, Woo P, Thomson W.

Ann Rheum Dis. 2017 May;76(5):906-913. doi: 10.1136/annrheumdis-2016-210324. Epub 2016 Dec 7.

19.

Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.

Horton N, Wu X, Philpott J, Garber A, Achkar JP, Brzezinski A, Lashner BA, Shen B.

Dig Dis Sci. 2016 Nov;61(11):3270-3277. Epub 2016 Sep 12.

PMID:
27619393
20.

The Significance of Sessile Serrated Polyps in Inflammatory Bowel Disease.

Jackson WE, Achkar JP, Macaron C, Lee L, Liu X, Pai RK, Lopez R, Burke CA, Allende DS.

Inflamm Bowel Dis. 2016 Sep;22(9):2213-20. doi: 10.1097/MIB.0000000000000895.

PMID:
27508509
21.

A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis.

Rivas MA, Graham D, Sulem P, Stevens C, Desch AN, Goyette P, Gudbjartsson D, Jonsdottir I, Thorsteinsdottir U, Degenhardt F, Mucha S, Kurki MI, Li D, D'Amato M, Annese V, Vermeire S, Weersma RK, Halfvarson J, Paavola-Sakki P, Lappalainen M, Lek M, Cummings B, Tukiainen T, Haritunians T, Halme L, Koskinen LL, Ananthakrishnan AN, Luo Y, Heap GA, Visschedijk MC; UK IBD Genetics Consortium; NIDDK IBD Genetics Consortium, MacArthur DG, Neale BM, Ahmad T, Anderson CA, Brant SR, Duerr RH, Silverberg MS, Cho JH, Palotie A, Saavalainen P, Kontula K, Färkkilä M, McGovern DP, Franke A, Stefansson K, Rioux JD, Xavier RJ, Daly MJ, Barrett J, de Lane K, Edwards C, Hart A, Hawkey C, Jostins L, Kennedy N, Lamb C, Lee J, Lees C, Mansfield J, Mathew C, Mowatt C, Newman B, Nimmo E, Parkes M, Pollard M, Prescott N, Randall J, Rice D, Satsangi J, Simmons A, Tremelling M, Uhlig H, Wilson D, Abraham C, Achkar JP, Bitton A, Boucher G, Croitoru K, Fleshner P, Glas J, Kugathasan S, Limbergen JV, Milgrom R, Proctor D, Regueiro M, Schumm PL, Sharma Y, Stempak JM, Targan SR, Wang MH.

Nat Commun. 2016 Aug 9;7:12342. doi: 10.1038/ncomms12342. Erratum in: Nat Commun. 2016 Sep 13;7:12869.

22.

A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome Composition.

Li D, Achkar JP, Haritunians T, Jacobs JP, Hui KY, D'Amato M, Brand S, Radford-Smith G, Halfvarson J, Niess JH, Kugathasan S, Büning C, Schumm LP, Klei L, Ananthakrishnan A, Aumais G, Baidoo L, Dubinsky M, Fiocchi C, Glas J, Milgrom R, Proctor DD, Regueiro M, Simms LA, Stempak JM, Targan SR, Törkvist L, Sharma Y, Devlin B, Borneman J, Hakonarson H, Xavier RJ, Daly M, Brant SR, Rioux JD, Silverberg MS, Cho JH, Braun J, McGovern DP, Duerr RH.

Gastroenterology. 2016 Oct;151(4):724-32. doi: 10.1053/j.gastro.2016.06.051. Epub 2016 Aug 1.

23.

Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction.

Chen T, Blanc C, Eder AZ, Prados-Rosales R, Souza AC, Kim RS, Glatman-Freedman A, Joe M, Bai Y, Lowary TL, Tanner R, Brennan MJ, Fletcher HA, McShane H, Casadevall A, Achkar JM.

J Infect Dis. 2016 Jul 15;214(2):300-10. doi: 10.1093/infdis/jiw141. Epub 2016 Apr 7.

24.

Anaerobic digestion of grape pomace: Biochemical characterization of the fractions and methane production in batch and continuous digesters.

El Achkar JH, Lendormi T, Hobaika Z, Salameh D, Louka N, Maroun RG, Lanoisellé JL.

Waste Manag. 2016 Apr;50:275-82. doi: 10.1016/j.wasman.2016.02.028. Epub 2016 Mar 2.

PMID:
26944865
25.

HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis.

Ombrello MJ, Remmers EF, Tachmazidou I, Grom A, Foell D, Haas JP, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Mellins ED, Ilowite NT, Russo R, Len C, Hilario MO, Oliveira S, Yeung RS, Rosenberg A, Wedderburn LR, Anton J, Schwarz T, Hinks A, Bilginer Y, Park J, Cobb J, Satorius CL, Han B, Baskin E, Signa S, Duerr RH, Achkar JP, Kamboh MI, Kaufman KM, Kottyan LC, Pinto D, Scherer SW, Alarcón-Riquelme ME, Docampo E, Estivill X, Gül A; British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group; Childhood Arthritis Prospective Study (CAPS) Group; Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators; Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group; Biologically Based Outcome Predictors in JIA (BBOP) Group, de Bakker PI, Raychaudhuri S, Langefeld CD, Thompson S, Zeggini E, Thomson W, Kastner DL, Woo P; International Childhood Arthritis Genetics (INCHARGE) Consortium.

Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):15970-5. doi: 10.1073/pnas.1520779112. Epub 2015 Nov 23.

26.

Host Protein Biomarkers Identify Active Tuberculosis in HIV Uninfected and Co-infected Individuals.

Achkar JM, Cortes L, Croteau P, Yanofsky C, Mentinova M, Rajotte I, Schirm M, Zhou Y, Junqueira-Kipnis AP, Kasprowicz VO, Larsen M, Allard R, Hunter J, Paramithiotis E.

EBioMedicine. 2015 Jul 30;2(9):1160-8. doi: 10.1016/j.ebiom.2015.07.039. eCollection 2015 Sep.

27.

Clinical and Radiographic Manifestations of Sputum Culture-Negative Pulmonary Tuberculosis.

Nguyen MV, Jenny-Avital ER, Burger S, Leibert EM, Achkar JM.

PLoS One. 2015 Oct 8;10(10):e0140003. doi: 10.1371/journal.pone.0140003. eCollection 2015.

28.

Gene-environment interactions in inflammatory bowel disease pathogenesis.

Wang MH, Achkar JP.

Curr Opin Gastroenterol. 2015 Jul;31(4):277-82. doi: 10.1097/MOG.0000000000000188. Review.

PMID:
26039718
29.

B cells and antibodies in the defense against Mycobacterium tuberculosis infection.

Achkar JM, Chan J, Casadevall A.

Immunol Rev. 2015 Mar;264(1):167-81. doi: 10.1111/imr.12276. Review.

30.

National trends in benign pulmonary resections: association with CT and PET imaging.

Hsu L, Achkar JM, Keller SM, Bailey JJ, Cohen HW, Haramati LB.

Chest. 2015 Feb;147(2):e61-e62. doi: 10.1378/chest.14-2423. No abstract available.

31.

Conventional risk factors and cardiovascular outcomes of patients with inflammatory bowel disease with confirmed coronary artery disease.

Aggarwal A, Atreja A, Kapadia S, Lopez R, Achkar JP.

Inflamm Bowel Dis. 2015 Jan;21(1):E2. doi: 10.1097/MIB.0000000000000275. No abstract available.

PMID:
25479460
32.

The role of B cells and humoral immunity in Mycobacterium tuberculosis infection.

Chan J, Mehta S, Bharrhan S, Chen Y, Achkar JM, Casadevall A, Flynn J.

Semin Immunol. 2014 Dec;26(6):588-600. doi: 10.1016/j.smim.2014.10.005. Epub 2014 Oct 28. Review.

33.

Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis.

Achkar JM, Chan J, Casadevall A.

Cold Spring Harb Perspect Med. 2014 Oct 9;5(3):a018432. doi: 10.1101/cshperspect.a018432. Review.

34.

Mycobacterial membrane vesicles administered systemically in mice induce a protective immune response to surface compartments of Mycobacterium tuberculosis.

Prados-Rosales R, Carreño LJ, Batista-Gonzalez A, Baena A, Venkataswamy MM, Xu J, Yu X, Wallstrom G, Magee DM, LaBaer J, Achkar JM, Jacobs WR Jr, Chan J, Porcelli SA, Casadevall A.

MBio. 2014 Sep 30;5(5):e01921-14. doi: 10.1128/mBio.01921-14.

35.

Impact of abdominal visceral adipose tissue on disease outcome in pediatric Crohn's disease.

Uko V, Vortia E, Achkar JP, Karakas P, Fiocchi C, Worley S, Kay MH.

Inflamm Bowel Dis. 2014 Dec;20(12):2286-91. doi: 10.1097/MIB.0000000000000200.

PMID:
25222655
36.

Hemoglobin and hematocrit levels in the prediction of complicated Crohn's disease behavior--a cohort study.

Rieder F, Paul G, Schnoy E, Schleder S, Wolf A, Kamm F, Dirmeier A, Strauch U, Obermeier F, Lopez R, Achkar JP, Rogler G, Klebl F.

PLoS One. 2014 Aug 12;9(8):e104706. doi: 10.1371/journal.pone.0104706. eCollection 2014.

37.

Conventional risk factors and cardiovascular outcomes of patients with inflammatory bowel disease with confirmed coronary artery disease.

Aggarwal A, Atreja A, Kapadia S, Lopez R, Achkar JP.

Inflamm Bowel Dis. 2014 Sep;20(9):1593-601. doi: 10.1097/MIB.0000000000000109.

PMID:
25105946
38.

Antibodies against Mycobacterial proteins as biomarkers for HIV-associated smear-negative tuberculosis.

Siev M, Wilson D, Kainth S, Kasprowicz VO, Feintuch CM, Jenny-Avital ER, Achkar JM.

Clin Vaccine Immunol. 2014 Jun;21(6):791-8. doi: 10.1128/CVI.00805-13. Epub 2014 Mar 26.

39.

Canadian Association of General Surgeons, the American College of Surgeons, the Canadian Society of Colorectal Surgeons and the American Society of Colorectal Surgeons Evidence Based Reviews in Surgery - colorectal surgery.

Brown CJ, Achkar JP, Bressler BL, Maclean AR, Remzi FH; Evidence Based Reviews in Surgery Group.

Dis Colon Rectum. 2014 Feb;57(2):278-81. doi: 10.1097/DCR.0000000000000012. Review. No abstract available.

PMID:
24401893
40.

Gene-gene and gene-environment interactions in ulcerative colitis.

Wang MH, Fiocchi C, Zhu X, Ripke S, Kamboh MI, Rebert N, Duerr RH, Achkar JP.

Hum Genet. 2014 May;133(5):547-58. doi: 10.1007/s00439-013-1395-z. Epub 2013 Nov 17.

41.

Interarytenoid botulinum toxin injection for recalcitrant vocal process granuloma.

Fink DS, Achkar J, Franco RA, Song PC.

Laryngoscope. 2013 Dec;123(12):3084-7. doi: 10.1002/lary.23915. Epub 2013 Sep 20.

PMID:
24115127
42.

Valencene synthase from the heartwood of Nootka cypress (Callitropsis nootkatensis) for biotechnological production of valencene.

Beekwilder J, van Houwelingen A, Cankar K, van Dijk AD, de Jong RM, Stoopen G, Bouwmeester H, Achkar J, Sonke T, Bosch D.

Plant Biotechnol J. 2014 Feb;12(2):174-82. doi: 10.1111/pbi.12124. Epub 2013 Sep 25.

43.
44.

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.

Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, Andreassen OA, Weersma RK, Weismüller TJ, Eksteen B, Invernizzi P, Hirschfield GM, Gotthardt DN, Pares A, Ellinghaus D, Shah T, Juran BD, Milkiewicz P, Rust C, Schramm C, Müller T, Srivastava B, Dalekos G, Nöthen MM, Herms S, Winkelmann J, Mitrovic M, Braun F, Ponsioen CY, Croucher PJ, Sterneck M, Teufel A, Mason AL, Saarela J, Leppa V, Dorfman R, Alvaro D, Floreani A, Onengut-Gumuscu S, Rich SS, Thompson WK, Schork AJ, Næss S, Thomsen I, Mayr G, König IR, Hveem K, Cleynen I, Gutierrez-Achury J, Ricaño-Ponce I, van Heel D, Björnsson E, Sandford RN, Durie PR, Melum E, Vatn MH, Silverberg MS, Duerr RH, Padyukov L, Brand S, Sans M, Annese V, Achkar JP, Boberg KM, Marschall HU, Chazouillères O, Bowlus CL, Wijmenga C, Schrumpf E, Vermeire S, Albrecht M; UK-PSCSC Consortium, Rioux JD, Alexander G, Bergquist A, Cho J, Schreiber S, Manns MP, Färkkilä M, Dale AM, Chapman RW, Lazaridis KN; International PSC Study Group, Franke A, Anderson CA, Karlsen TH; International IBD Genetics Consortium.

Nat Genet. 2013 Jun;45(6):670-5. doi: 10.1038/ng.2616. Epub 2013 Apr 21.

45.

A novel approach to detect cumulative genetic effects and genetic interactions in Crohn's disease.

Wang MH, Fiocchi C, Ripke S, Zhu X, Duerr RH, Achkar JP.

Inflamm Bowel Dis. 2013 Aug;19(9):1799-808. doi: 10.1097/MIB.0b013e31828706a0.

46.

Immunogenicity of mycobacterial vesicles in humans: identification of a new tuberculosis antibody biomarker.

Ziegenbalg A, Prados-Rosales R, Jenny-Avital ER, Kim RS, Casadevall A, Achkar JM.

Tuberculosis (Edinb). 2013 Jul;93(4):448-55. doi: 10.1016/j.tube.2013.03.001. Epub 2013 Apr 2.

47.

Antibody-mediated immunity against tuberculosis: implications for vaccine development.

Achkar JM, Casadevall A.

Cell Host Microbe. 2013 Mar 13;13(3):250-62. doi: 10.1016/j.chom.2013.02.009. Review.

48.

Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253.

Swindells S, Komarow L, Tripathy S, Cain KP, MacGregor RR, Achkar JM, Gupta A, Veloso VG, Asmelash A, Omoz-Oarhe AE, Gengiah S, Lalloo U, Allen R, Shiboski C, Andersen J, Qasba SS, Katzenstein DK; AIDS Clinical Trials Group 5253 Study Team.

Int J Tuberc Lung Dis. 2013 Apr;17(4):532-9. doi: 10.5588/ijtld.12.0737.

49.

PTGER4 expression-modulating polymorphisms in the 5p13.1 region predispose to Crohn's disease and affect NF-κB and XBP1 binding sites.

Glas J, Seiderer J, Czamara D, Pasciuto G, Diegelmann J, Wetzke M, Olszak T, Wolf C, Müller-Myhsok B, Balschun T, Achkar JP, Kamboh MI, Franke A, Duerr RH, Brand S.

PLoS One. 2012;7(12):e52873. doi: 10.1371/journal.pone.0052873. Epub 2012 Dec 27.

50.

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, Büning C, Cohain A, Cichon S, D'Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Hu X, Karlsen TH, Kupcinskas L, Kugathasan S, Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhao H; International IBD Genetics Consortium (IIBDGC), Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC, Cho JH.

Nature. 2012 Nov 1;491(7422):119-24. doi: 10.1038/nature11582.

Supplemental Content

Loading ...
Support Center